Biblio
Export 1713 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is C [Clear All Filters]
“A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.”, J Alzheimers Dis, vol. 53, no. 2, pp. 475-85, 2016.
, “A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.”, J Alzheimers Dis, vol. 53, no. 2, pp. 475-85, 2016.
, “A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.”, J Alzheimers Dis, vol. 53, no. 2, pp. 475-85, 2016.
, “N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort.”, J Alzheimers Dis, vol. 54, no. 2, pp. 497-503, 2016.
, “N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort.”, J Alzheimers Dis, vol. 54, no. 2, pp. 497-503, 2016.
, “Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1.”, J Alzheimers Dis, vol. 52, no. 1, pp. 33-42, 2016.
, “An Optimized Combination of Ginger and Peony Root Effectively Inhibits Amyloid-β Accumulation and Amyloid-β-Mediated Pathology in AβPP/PS1 Double-Transgenic Mice.”, J Alzheimers Dis, vol. 50, no. 1, pp. 189-200, 2016.
, “Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1121-32, 2016.
, “Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1479-85, 2016.
, “The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 681-93, 2016.
, “Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 81-95, 2016.
, “Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 81-95, 2016.
, “Pain Assessment in Elderly with Behavioral and Psychological Symptoms of Dementia.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1217-25, 2016.
, “Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases.”, J Alzheimers Dis, vol. 54, no. 3, pp. 995-1004, 2016.
, “Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1419-32, 2016.
, “Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1419-32, 2016.
, “Patients with Mild Alzheimer's Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique.”, J Alzheimers Dis, vol. 50, no. 3, pp. 827-38, 2016.
, “Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 687-98, 2016.
, “Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.”, J Alzheimers Dis, vol. 54, no. 1, pp. 55-67, 2016.
, “Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.”, J Alzheimers Dis, vol. 54, no. 1, pp. 55-67, 2016.
, “Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.”, J Alzheimers Dis, vol. 54, no. 1, pp. 55-67, 2016.
, “Performance on Specific Cognitive Domains and Cause of Death: A Prospective Population-Based Study in Non-Demented Older Adults (NEDICES).”, J Alzheimers Dis, vol. 51, no. 2, pp. 533-44, 2016.
, “Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 1, pp. 349-61, 2016.
, “Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 1, pp. 349-61, 2016.
, “A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 777-87, 2016.
,